Rapid advancements in live cell imaging technology, government initiatives to promote stem cell research, and increasing investments in research and development activities are key factors fueling global market growth.
Rapid advancements in live cell imaging technology, government initiatives to promote stem cell research, and increasing investments in research and development activities are key factors fueling global market growth
The global live cell imaging market is expected to reach USD 4.35 billion in 2028 and register a revenue CAGR of 9.12% during the forecast period, according to latest report published by Reports and Data. Key factors driving global market revenue growth include increasing prevalence of cancer across the globe, high adoption of live cell imaging in research centers and diagnostic centers, and rising number of pharmaceutical and biopharmaceutical companies worldwide.
Live cell imaging is a microscopy technique that enables in vivo imaging of cells in real time over a period of time. It is commonly used in research centers and laboratories by researchers and laboratory technicians to obtain details about cell structures, cellular responses, and interactions between molecules. It helps in monitoring live cells over time in regulated environmental conditions and acquiring 4D images of cells laterally, axially, and temporally. Rapid advancements in live cell imaging and automated microscopes have made drug discovery and cell analysis easier. Factors such as rising prevalence of chronic diseases such as cancer, diabetes, heart, and neurological diseases, rising demand for fluoresce microscopy, and increasing investments in developing advanced equipment are expected to fuel global market growth during the forecast period.
Access Free sample PDF Copy of the Report @ https://www.reportsanddata.com/sample-enquiry-form/1749
However, high initial investment required for the deployment of high content screening systems, lack of funds, and budget shortage in many pharmaceutical companies, research laboratories, and dearth of skilled laborers and laboratory technicians, especially in developing countries are expected to hamper overall market growth during the forecast period.
Some key highlights of the report:
- Based on technology, the High Content Screening (HCS) segment is expected to register rapid revenue CAGR during the forecast period. Factors such as rising global prevalence of chronic diseases such as cancer and heart diseases, increasing demand for advanced imaging techniques, ongoing research on drug discovery, and growing preference toward high-content screening for rapid and unbiased results are expected to drive revenue growth of the segment.
- Among the end use segments, the pharmaceutical and biotechnology segment is expected to register highest revenue growth between 2021 and 2028 owing to high patient pool, increasing investments in research and development activities, and increasing adoption of advanced live cell imaging systems.
- Europe market is expected to register significantly high revenue growth between 2021 and 2028 owing to factors such as increasing prevalence of cancer, degenerative diseases, cardiac diseases; increasing investments in research and development activities, and the presence of well-developed research centers and facilities. Other factors such as a favorable regulatory environment, more focus on developing advanced live cell imaging techniques, and increasing investments in regenerative medicine are expected to fuel market growth during the forecast period.
- Asia Pacific is expected to register fastest revenue CAGR during the forecast period owing to increasing investments in regenerative medicine research, rising incidence of cancer and other diseases, and improved healthcare and research facilities. In addition, increasing investments in research and development activities, increasing adoption of advanced live cell imaging technology, and rising number of pharmaceutical, biopharmaceutical companies in the region is expected to fuel market growth between 2021 and 2028.
- Carl Zeiss Meditec AG, Leica Microsystems, Nikon Corporation, Becton, Dickinson and Company, GE Healthcare, Olympus Corporation, Thermo Fisher Scientific, Sigma-Aldrich Corporation, PerkinElmer, Inc., Molecular Devices LLC, BioTek Instruments, Inc., NanoEnTek, Inc., Bruker Corporation, Merck KGaA, Cytoskeleton, Inc., Tomocube, Inc., Sartorius AG, Etaluma, Inc., Cytosmart Technologies, Phase Focus Limited, and Phase Holographic Imaging are some key companies operating in the live cell imaging market.
Get In detailed Research Study @ https://www.reportsanddata.com/report-detail/live-cell-imaging-market
For the purpose of this report, Reports and Data has segmented the global live cell imaging market on the basis of product, application, technology, end use, and region:
Product Outlook (Revenue, USD Billion; 2018–2028)
- Instruments
- Microscopes
- Cell Analyzers
- Image Capturing Systems
- Standalone Systems
- Consumables
- Reagents
- Assay Kits
- Media
- Others
- Software & Services
- Others
Technology Outlook (Revenue, USD Billion; 2018–2028)
- Fluorescence Resonance Energy Transfer (FRET)
- Time Lapse Microscopy
- Fluorescence Recovery After Photobleaching (FRAP)
- High Content Screening (HCS)
- Others
Application Outlook (Revenue, USD Billion; 2018–2028)
- Cell Biology
- Stem Cells
- Developmental Biology
- Drug Discovery
- Others
End-Use Outlook (Revenue, USD Billion; 2018–2028)
- Pharmaceutical and Biotechnology Companies
- Research Institutes
- Hospitals
- Diagnostic Laboratories
- Other
Download Summary @ https://www.reportsanddata.com/download-summary-form/1749
Regional Outlook (Revenue, USD Billion, 2018-2028)
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Italy
- Spain
- Sweden
- Benelux
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of APAC
- Latin America
- Brazil
- Rest of LATAM
- Middle East & Africa
- Saudi Arabia
- UAE
- South Africa
- Israel
- Rest of MEA
Ask for Customize Research Report @ https://www.reportsanddata.com/request-customization-form/1749
Some points on how the report benefits stakeholders:
- The reports include historical (2018–2020) and forecast (2021–2028) data points, revenues, and CAGR in table, figure, and chart formats, with detailed and qualitative, supporting written information for each.
- Revenue break-up is provided for each segment in these formats for global, regional, and for each country in the respective region for each year between 2018 and 2028.
- The report contains insights regarding growth drivers, restraints, opportunities, trends, company profiles, strategic developments, expansion details, product launches, and various other aspects related to the market.
- The report contains data and information on customers, competitors, vendors/distributors, and other players and in the global marketplace.
- Market research analysis is vital for all crucial business strategies and can aid in numerous ways and to provide a clearer understanding about strategies being deployed by competitors, product launches, competitive analysis, technological advancements and various other factors that enhance sales of a firm or perhaps provide insights to focus on merger and acquisition as a strategy or enter into strategic agreements or joint ventures etc.
- The report contains company profiles of the top companies operating in the market along with their respective revenue and operating segments, geographical reach, market footprint, headquarters, growth rates, recent developments, product /services, expansion strategies, investments in expansion, and more.
Explore Latest Trending Research Reports By Reports and Data’s
Nasal Masks Market Growth, Trends & Analysis, By Product (Masks, Tubes, Others), By End-Use (Hospitals, Clinics, Homecare Settings, Others), By Distribution Channel (Pharmacies, Online Stores, Direct Distributors, Others) By Region, Forecast To 2027
Facial Erythema Therapeutics Market Size, Trends & Analysis By Drug Type (Antibiotics, Antifungal, Antihistamines, Corticosteroids), By Mode of Administration (Topical and Oral), By Region, Forecast to 2027
Albuterol Sulfate Metered Dose Inhalers Market Size, Growth & Analysis, By Product Type (90 mcg, 108 mcg, 120 mcg), By End-User (Kids, Adults), By Region, Forecast To 2027
Besponsa Market Size, Growth & Analysis, By Product Type (0.9mg, 1.0mg), By Application (Hospital, Pharmacy), By Region, Forecast to 2027
Carotid Stents System Market Share, Growth & Analysis, By Type (Balloon Expandable Stents And Self-Expanding Stents), By Material (Metallic Stents And Other Stents), By End-User (Hospitals, Cardiac Centers, And Ambulatory Surgical Centers), By Region, Forecast To 2027
About Reports and Data
Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients to make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Products, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.
Contact Us:
John W
Head of Business Development
Reports And Data | Web: www.reportsanddata.com
Direct Line: +1-212-710-1370
E-mail: sales@reportsanddata.com
LinkedIn | Twitter | Blogs
Read Latest Press Release @ https://www.reportsanddata.com/press-release/global-live-cell-imaging-market